Slide 1: Investor Presentation Q2/H1 - 2024/25
Investor Presentation Q2/H1 - 2024/25 This presentation contains statements regarding expectations for the future development of RTX A/S, including future revenue and operating profit (EBITDA), reflect Management’s current outlook and carry some uncertainty. These statements can be affected by a num
Slide 2: A significant improvement in the global technology company RTX
A significant improvement in the global technology company RTX › Growth in Enterprise › Growing Healthcare revenue › Tariff creates uncertainty 2024/25 Q2/H1 - RTX - Investor Presentation 2
Slide 3: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 3
Slide 4: Helping people perform at their best
Helping people perform at their best Utilizing wireless expertise, we provide secure and reliable communication products and solutions, fit for challenging environments 2024/25 Q2/H1 - RTX - Investor Presentation 4
Slide 5: Creating value through trusted partnerships
Creating value through trusted partnerships Enabling global leaders to focus on brand and market development by designing and producing high-quality communication products and solutions 2024/25 Q2/H1 - RTX - Investor Presentation 5
Slide 6: Trusted partnerships throughout the product lifecycle
Trusted partnerships throughout the product lifecycle Branding and Sales Distribution Support Customers Market Requirements marketing analysis and design Support and Market Collaborative product development Go-to-market Sales, production, and distribution lifecycle research management Onboarding Pro
Slide 7: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 7
Slide 8: Enterprise products and customers
Enterprise products and customers 2024/25 Q2/H1 - RTX - Investor Presentation 8
Slide 9: Enterprise update
Enterprise update Infrastructure, Handset, and Headset Highlights › Growth driven primarily by retail and normalization in key customer demand patterns › Continuously strong orderbook from several long-term customers › Order horizon remains short at three to six months Revenue Q2: 114 DKKm H1: 193 D
Slide 10: Enterprise – Retail insights
Enterprise – Retail insights Value creation › Labour efficiency › Customer experience › Operational excellence 2024/25 Q2/H1 - RTX - Investor Presentation 10
Slide 11: Healthcare products, customers and potential partners
Healthcare products, customers and potential partners Customers Devices and monitoring Hospital IT infrastructure 2024/25 Q2/H1 - RTX - Investor Presentation 11
Slide 12: Healthcare update
Healthcare update Infrastructure for patient monitoring solutions Highlights › Revenue for the quarter on key infrastructure products and modules for patient monitoring devices › Building up orderbook on key products › Transition to full product ownership and seamless integration in progress with pa
Slide 13: ProAudio – Secure and reliable sound
ProAudio – Secure and reliable sound Standard RTX modules Software solutions › TeamEngage® › Sheerlink® › Sheersound® 2024/25 Q2/H1 - RTX - Investor Presentation 13
Slide 14: ProAudio update
ProAudio update Connectivity modules for professional audio solutions Highlights › Revenue is below expectations, reflecting a lower volume from key customers and a longer development time for new customers › Strategic focus on module business, reduction in product business where we experience lower
Slide 15: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 15
Slide 16: Selected insights – US tariffs impact on RTX
Selected insights – US tariffs impact on RTX Current Tariffs RTX Production footprint & Operating Model At key production sites* › Customers are the importers of goods 10% 30% 10% Philippines China Denmark › RTX has an asset-light setup and production partner with global footprint › Optimization of
Slide 17: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 17
Slide 18: Interim Report H1 2024/25
Interim Report H1 2024/25 2024/25 Q2/H1 - RTX - Investor Presentation 18
Slide 19: Revenue
Revenue Revenue DKK million Revenue 498 300 500 Q2: 160 DKKm Revenue Q2 2023/24: 125 DKKm 250 349 400 260 300 H1: 260 DKKm 200 207 Revenue H1 2023/24: 207 DKKm 200 150 101 82 100 • Strong performance in Enterprise from key customers 100 160 0 • Revenue as expected for H1 for Healthcare 142 149 125 •
Slide 20: Gross Margin
Gross Margin Gross Margin % Gross Margin 150 60 Q2: 49.7 % Gross margin Q2 2023/24: 45.6% 50 50,8% 50,1% H1: 50.1 % 100 42,9% 44,9% 46,7% 40 Gross margin H1 2023/24: 42.9% 38,9% 30 As anticipated, we see a robust gross margin in 50 H1. This is a result of both product mix, 20 healthcare revenue and
Slide 21: EBITDA
EBITDA EBITDA DKK million EBITDA 100 50 Q2: 16.6 DKKm EBITDA Q2 2023/24: 0.9 DKKm 80 0 7 3 H1: 7.2 DKKm 60 -9 -20 EBITDA H1 2023/24: -29.5 DKKm 40 -31 -30 -50 20 17 -100 23 1 9 The development in EBITDA for the period is 0 impacted mainly by the revenue level and -9 -31 -150 improved gross margin co
Slide 22: Other key financial highlight
Other key financial highlight Inventory Net liquidity position Free Cash Flow H1: 74 DKKm H1: 108 DKKm H1: 7 DKKm LY: 100 DKKm LY: 87 DKKm LY: -35 DKKm Inventory end of H1 reached Net liquidity position end of Free Cash flow for the quarter 74 DKKm, down from 82 H1 reached 108 DKKm, up was positive
Slide 23: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 23
Slide 24: Outlook FY - 2024/25
Outlook FY - 2024/25 2024/25 Financial Outlook 2024/25 Outlook is maintained As communicated in annual report November 2024 Revenue: Revenue: 490 to 520 DKKm › Growth in Enterprise and Healthcare › Short visibility gives insight on 3-6 months forecast › Orderbook is building up EBITDA / EBIT: EBITDA
Slide 25: Agenda
Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 25
Slide 26: Questions?
Questions? 2024/25 Q2/H1 - RTX - Investor Presentation 26